Also trades as: ACHFF (OTC) · $vol 0M
ARCH.V TSXV
Arch Biopartners Inc.
1W: +0.0%
1M: -18.4%
3M: -8.7%
YTD: -5.6%
1Y: -49.1%
3Y: -53.3%
5Y: -52.5%
C$0.83 ($0.58)
+0.00 (+0.00%)
Weekly Expected Move ±9.2%
C$1
C$1
C$1
C$1
C$1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$0
-100.0% ▼
Gross Profit
$0
+100.0% ▲
Operating Income
-$2M
+61.6% ▲
Net Income
-$2M
+60.4% ▲
EPS (Diluted)
$-0.02
+61.7% ▲
EBITDA
-$1M
+63.3% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $4M | $965K | $2M | $2M | $0 |
| YoY Growth | +5625.8% | -75.2% | +105.7% | +7.0% | -100.0% |
| Cost of Revenue | $4M | $1M | $2M | $4M | $0 |
| Gross Profit | -$150K | -$503K | -$129K | -$2M | $0 |
| Gross Margin | -3.9% | -52.1% | -6.5% | -78.0% | — |
| R&D Expenses | $4M | $1M | $2M | $4M | -$10K |
| SG&A Expenses | $650K | $773K | $3M | $2M | $1M |
| Operating Expenses | $1M | $1M | $3M | $2M | $2M |
| Operating Income | -$1M | -$1M | -$3M | -$4M | -$2M |
| Operating Margin | -30.0% | -144.0% | -169.1% | -186.0% | — |
| Interest Expense | $273K | $309K | $359K | $389K | $258K |
| Income Before Tax | -$1M | -$1M | -$3M | -$4M | -$2M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$1M | -$1M | -$3M | -$4M | -$2M |
| Net Margin | -30.1% | -146.0% | -167.7% | -184.7% | — |
| EPS (Diluted) | $-0.02 | $-0.02 | $-0.05 | $-0.06 | $-0.02 |
| EBITDA | -$77K | -$101K | -$336K | -$4M | -$1M |
| Shares Outstanding | 61M | 62M | 62M | 63M | 66M |